Skip to main content

ORIGINAL RESEARCH article

Front. Surg., 18 May 2022
Sec. Visceral Surgery
This article is part of the Research Topic Co-use of medicines in surgery View all 114 articles

Evaluation of Serum AMH, INHB Combined with Basic FSH on Ovarian Reserve Function after Laparoscopic Ovarian Endometriosis Cystectomy

  • Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China

Objective: The value of serum AMH, INHB, and bFSH levels in assessing postoperative ovarian reserve function was analyzed by measuring serum anti-Mullerian hormone (AMH), inhibin B (INHB), and basal follicle-stimulating hormone (bFSH) levels in patients after laparoscopic cystectomy for endometrioma.

Methods: From June 2019 to December 2021, 124 patients underwent laparoscopic cystectomy for endometrioma in our hospital were selected, and the serum AMH, INHB, bFSH level, antral follicle count (AFC) of all patients before and after operation were detected and compared. According to the results of postoperative testing, all the patients were divided into normal group (n = 86), diminished ovarian reserve (DOR) group (n = 27), and premature ovarian failure (POF) group (n = 11). Pearson correlation model and subject operating characteristic curve (ROC) were used to analyze the correlation and diagnostic value of serum AMH, INHB and bFSH levels with postoperative ovarian reserve function, respectively.

Results: After operation, the levels of serum AMH, INHB and AFC in the DOR group and POF group decreased compared with those before the operation, and the serum bFSH levels increased (p < 0.05). After operation, the levels of serum AMH, INHB and AFC in DOR group and POF group were lower than those in normal group,and the serum bFSH levels were higher than the normal group; the levels of serum AMH, INHB and AFC in POF group were lower than those in DOR group, and the serum bFSH levels were higher than the DOR group (p < 0.05). Pearson analysis showed that serum AMH and INHB levels were negatively correlated with bFSH, and positively correlated with the number of AFC, the serum bFSH level was negatively correlated with the number of AFC (p < 0.05). The diagnostic values of serum AMH, bFSH, INHB and the combination of the three tests for postoperative abnormal ovarian reserve function were 0.866 (95% CI, 0.801–0.923), 0.810 (95% CI, 0.730–0.890), 0.774 (95% CI, 0.687–0.860) and 0.940 (95% CI, 0.900–0.981), respectively.

Conclusion: Serum AMH and INHB levels decreased and bFSH levels increased in patients after laparoscopic cystectomy for endometrioma, both of which were closely related to postoperative ovarian reserve function, and both could evaluate ovarian reserve function after ovarian cyst debulking, and the combined test could significantly improve the detection rate.

Introduction

Ovarian endometriotic cysts (OEMC), or chocolate cysts, are the most predominant pathological type of endometriosis, and OEMC mainly presents with dysmenorrhea, non-menstrual chronic pelvic pain, and in severe cases, infertility, which seriously affects the physical and mental health of patients (1). Laparoscopic debridement of cysts is currently the best method for the treatment of ovarian endometrial cysts, with the advantages of superior results, low postoperative recurrence rate and minimal trauma. Although surgery can remove lesions and relieve symptoms, postoperative risk events such as formation of venous thrombosis, intraoperative bleeding, postoperative infection, adhesion formation, and postoperative reduction of ovarian reserve function and recurrence of postoperative endometriosis can occur (2, 3). Reduced ovarian reserve function is a key factor in infertility in patients with endometriosis; therefore, it is important to fully grasp the postoperative ovarian reserve function of patients and to provide targeted treatment.

Anti-mullerian hormone (AMH) is considered to be an ideal indicator to evaluate ovarian reserve function and is positively correlated with the number of small antral follicles, which can reflect the number of early follicles in the ovary and the survival of primordial follicles (4, 5). Inhibin B (INHB) is produced by small antral follicles, in addition to assessing ovarian reserve, it can also stabilize T cell function and inhibit the overactivation of immune factors from causing damage to ovarian epithelial tissue (6, 7). Basic follicle stimulating hormone (bFSH) promotes follicle maturation, regulates growth and development, and is likewise used to assess ovarian reserve function (8). In this study, we investigated the value of serum AMH, INHB, and bFSH levels in assessing the postoperative ovarian reserve function of patients after laparoscopic ovarian endometriosis cyst debulking by measuring their serum AMH, INHB, and bFSH levels. The specific research is shown as follows.

Materials and Methods

General Information

124 patients who underwent laparoscopic ovarian endometrioma cystectomy in our hospital from June 2017 to December 2019 were selected, aged 21–39 years, with an average age of (28.17 ± 5.71) years. Inclusion criteria: a diagnosis of OEMC or other benign ovarian lesions based on the patient's clinical presentation and imaging.; unilateral cystic lesions; normal menstruation; no history of taking sex hormone drugs within 3 months; no history of uterine-related surgery. Exclusion criteria: combined with endocrine diseases; combined with ovarian malignant tumors and other malignant tumors; patients with abnormal ovarian function such as polycystic ovaries; history of hormonal drug use within 6 months and history of pregnancy and lactation.

Research Methods

Cyst removal: All patients underwent laparoscopic cyst removal by the same group of physicians, i.e., the patient was put under general anesthesia, a pneumoperitoneum was established, a laparoscope was placed, the ovarian cortex was opened with an electric needle after exploration. The ovarian cortex was cut, the cyst wall was removed, the wound was electrocoagulated to stop bleeding, and the cyst was removed.

Serum AMH, INHB, bFSH levels and small antral follicle count (AFC) detection: 5 mL of cubital venous blood was drawn from the patient on the 2nd or 3rd day of preoperative menstruation and on the 2nd or 3rd day of postoperative menstrual period, and then centrifuged for 20 min at 3,000 r/min after 2 h resting. Serum AMH and INHB levels were measured by ELISA (kits purchased from Shanghai Kanglang Biotechnology Co., Ltd.), serum bFSH levels were measured by radioimmunoassay (kits purchased from Shanghai mlbio Co., Ltd.), and AFC was examined by ultrasound. According to the postoperative detection results, they were divided into normal group (86 cases), diminished ovarian reserve (DOR) group (27 cases), and premature ovarian failure (POF) group (11 cases). According to our standard determination, the normal levels of AMH were 2.00–10.00 ng/mL, INHB were 20–175 pg/mL, bFSH were 4–12 U/L, and AFC were ≥4. Normal group: all indexes and menstruation were normal. dOR group: serum bFSH was 12–40 U/L, AFC <4, regular menstrual cycle; POF group: serum bFSH >40 U/L, amenorrhea >6 months.

Statistical Methods

SPSS 22.0 software was used for processing data. The measurement data were expressed as, and the comparison was performed by one-way ANOVA, and the pairwise comparison was performed by the SNK-q method. Enumeration data were expressed as frequency and percentage [n(%)], and the χ2 test was used. Correlation analysis was performed by using Pearson correlation analysis. The receiver operating characteristic curve (ROC) was drawn, and the area under the ROC curve (AUC) was used to evaluate the diagnostic value of serum AMH, INHB, and bFSH levels on ovarian reserve, and AUC > 0.7 was considered diagnostic significance. p < 0.05 means the difference was statistically significant.

Results

Comparison of Postoperative Serum AMH, INHB, bFSH, and AFC in Three Groups of Patients

Preoperatively, there were no significant differences in serum AMH, INHB, bFSH levels and AFC counts among the three groups (p > 0.05). Postoperative serum AMH, INHB levels and number of AFC in the DOR and POF groups decreased compared with those before surgery and were lower than those in the normal group in the same period, while serum bFSH levels increased and were higher than those in the normal group in the same period, and the differences were statistically significant (p < 0.05). The postoperative serum AMH, INHB levels and number of AFC in the POF group were lower than those in the DOR group, and the serum bFSH levels were higher than those in the DOR group, and the differences were statistically significant (p < 0.05). See Figure 1.

FIGURE 1
www.frontiersin.org

Figure 1. Comparison of postoperative serum AMH, INHB, bFSH and AFC in patients (n, x̅±s). Note: (A) is AMH, (B) is INHB, (C) is bFSH, and (D) is AFC. Compared with the same group preoperatively *p < 0.05; compared with normal group after operation, #p < 0.05; compared with DOR group after operation, p < 0.05.

Correlation Analysis Between Serum AMH, INHB, bFSH Levels and Postoperative Ovarian Reserve

Pearson analysis showed that serum AMH and INHB levels were negatively correlated with bFSH, and positively correlated with the number of AFCs; serum bFSH level was negatively correlated with the number of AFCs, as shown in Table 1.

TABLE 1
www.frontiersin.org

Table 1. Correlation analysis between serum AMH, INHB, bFSH levels and postoperative ovarian reserve.

The Diagnostic Value of Serum AMH, INHB Combined With bFSH on Postoperative Ovarian Reserve

The AUC of the predictive value of serum AMH for postoperative abnormal ovarian reserve function was 0.866 (95% CI, 0.801–0.923), with a sensitivity of 88.10% and specificity of 88.30% when the best cut-off value was 0.621; the AUC of the predictive value of serum INHB for postoperative abnormal ovarian reserve function was 0.810 (95% CI, 0.730–0.890), with a sensitivity of 65.00% and specificity of 87.80% when the best cut-off value was 0.528; the AUC of the predictive value of serum bFSH for abnormal postoperative ovarian reserve function was 0.774 (95% CI, 0.687–0.860), with a sensitivity of 68.30% and specificity of 77.60%. The AUC of the predictive value of serum AMH and INHB combined with bFSH for abnormal postoperative ovarian reserve function was 0.940 (95% CI, 0.900–0.981), and when the best cut-off value was 0.638, the sensitivity was 90.10% and the specificity was 89.20%. See Table 2 and Figure 2.

FIGURE 2
www.frontiersin.org

Figure 2. The diagnostic value of serum AMH, INHB combined with bFSH on postoperative ovarian reserve.

TABLE 2
www.frontiersin.org

Table 2. Diagnostic value of serum AMH, INHB combined with bFSH for postoperative ovarian reserve.

Discussion

Laparoscopic treatment has a high clearance rate for OEMC, but because of the tight connection between the cyst and normal ovarian tissue, intraoperative operations such as cyst wall stripping and hemostasis can easily cause follicle loss, resulting in compromised ovarian reserve function in patients (9, 10). Therefore, strengthening the screening of ovarian reserve after cyst dissection is of great significance for early intervention and improvement of patients’ prognosis.

AMH is secreted by granulosa cells and its levels are relatively stable during the menstrual cycle. Its level reflects the number of primary follicles and regulates follicle maturation and development, thus it can be used as a serological marker to assess ovarian reserve function and ovarian responsiveness during ovulation (11, 12). INHB is also secreted by granulosa cells and its abnormal level is closely related to the abnormal function of ovarian granulosa cells, which can feedback inhibit the production of bFSH, while bFSH can promote the production of INHB by granulosa cells. In addition, INHB can also regulate the secretion of estradiol (E2), which can be used to evaluate ovarian reserve function (13, 14). AFC is a proven reliable index to assess ovarian reserve function, negatively correlated with patient age and closely related to ovarian responsiveness during the ovulatory cycle, which can truly reflect the patient's ovarian functional reserve (15). The results of this study showed that postoperative serum AMH, INHB levels and number of AFC in the DOR and POF groups decreased compared with those before surgery and were lower than those in the normal group in the same period, while serum bFSH levels increased and were higher than those in the normal group in the same period. The postoperative serum AMH, INHB levels and number of AFC in the POF group were lower than those in the DOR group, and the serum bFSH levels were higher than those in the DOR group Pearson analysis showed that serum AMH and INHB levels were negatively correlated with bFSH, positively correlated with AFC count, and serum bFSH level was negatively correlated with AFC count. All of these results indicate that serum AMH, INHB, and bFSH are all associated with ovarian function after laparoscopic ovarian endometriosis cyst debulking and that their serological levels change with changes in postoperative ovarian reserve function. It has been suggested that reduced serum AMH and INHB levels are associated with abnormal function of follicular granulosa cells, while reduced serum INHB levels make them less inhibitory to serum bFSH, which in turn causes abnormal ovarian reserve function in patients (16, 17).

Serum bFSH can be used as one of the important indicators for evaluating ovarian reserve function, but some studies (18) found that the serum bFSH level of some patients did not increase after cystectomy. Analysis of the reasons for this may be related to the fact that the patient had only one ovary removed and the other ovary could replace the function of the affected ovary. Therefore, the evaluation of ovarian reserve function after ovarian cyst debulking using serum bFSH alone has the problem of poor specificity and sensitivity. Both Serum AMH and INHB belong to the transforming growth factor-β superfamily, and both serum levels are positively correlated with ovarian responsiveness and follicle number, both of which can be used to assess ovarian reserve function (19, 20). The results of this study found that the AUC of serum AMH, INHB, bFSH and the combination of the three for abnormal ovarian reserve after ovarian cystectomy were 0.866, 0.810, 0.774, and 0.940, respectively, which indicated that compared with serum bFSH, INHB and AMH alone for predicting ovarian reserve function after ovarian cyst debulking, the combined test significantly improve the detection rate of abnormal postoperative ovarian reserve function.

In conclusion, serum AMH and INHB levels decreased and bFSH levels increased in patients after laparoscopic cystectomy for endometrioma, which were closely related to postoperative ovarian reserve function and could be evaluated for ovarian reserve function after ovarian cystectomy, and the combined test can significantly improve the detection rate and facilitate the targeted treatment of patients.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.

Ethics Statement

The studies involving human participants were reviewed and approved by The medical ethics committee of our institution has given its consent to this study (2018004). The patients/participants provided their written informed consent to participate in this study.

Author Contributions

The first author is YT, she is responsible for the writing,research design,data analysis of the article. YL is responsible for the guidance of the entire research. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Lee HJ, Lee JS, Lee YS. Comparison of serum antimüllerian hormone levels after robotic-assisted vs. laparoscopic approach for ovarian cystectomy in endometrioma. Eur J Obstet Gynecol Reprod Biol. (2020) 249:9–13. doi: 10.1016/j.ejogrb.2020.04.010

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Garcia-Tejedor A, Martinez-Garcia JM, Candas B, Suarez E, Mañalich L, Gomez M, et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study. J Minim Invasive Gynecol. (2020) 27:1133–40. doi: 10.1016/j.jmig.2019.08.036

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Cagnacci A, Bellafronte M, Xholli A, Palma F, Carbone MM, Di Carlo C, et al. Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry. Gynecol Endocrinol. (2016) 32:298–301. doi: 10.3109/09513590.2016.1142523

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Leiper A, Houwing M, Davies EG, Rao K, Burns S, Morris E, et al. Anti-Müllerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens. Bone Marrow Transplant. (2020) 55:1985–95. doi: 10.1038/s41409-020-0866-9

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Wu CH, Yang SF, Tsao HM, Chang YJ, Lee TH, Lee MS. Anti-Müllerian hormone gene polymorphism is associated with clinical pregnancy of fresh IVF cycles. Int J Environ Res Public Health. (2019) 16:841. doi: 10.3390/ijerph16050841

CrossRef Full Text | Google Scholar

6. Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. (2020) 105:3361–73. doi: 10.1210/clinem/dgaa513

CrossRef Full Text | Google Scholar

7. Koller T, Kollerová J, Hlavatý T, Kadlečková B, Payer J. Ovarian reserve assessed by the anti-mullerian hormone and reproductive health parameters in women with crohńs disease, a case-control study. Physiol Res. (2021) 70:S69–S78. doi: 10.33549/physiolres.934776

CrossRef Full Text | Google Scholar

8. Toner JP, Seifer DB. Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone. Fertil Steril. (2013) 99:1825–30. doi: 10.1016/j.fertnstert.2013.03.001

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Shaltout MF, Elsheikhah A, Maged AM, Elsherbini MM, Zaki SS, Dahab S, et al. A randomized controlled trial of a new technique for laparoscopic management of ovarian endometriosis preventing recurrence and keeping ovarian reserve. J Ovarian Res. (2019) 12(1):66. doi: 10.1186/s13048-019-0542-0

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Karadağ C, Demircan S, Turgut A, Çalışkan E. Effects of laparoscopic cystectomy on ovarian reserve in patients with endometrioma and dermoid cyst. Turk J Obstet Gynecol. (2020) 17:15–20. doi: 10.4274/tjod.galenos.2020.37605

CrossRef Full Text | Google Scholar

11. Anckaert E, Denk B, He Y, Torrance HL, Broekmans F, Hund M. Evaluation of the Elecsys? anti-Müllerian hormone assay for the prediction of hyper-response to controlled ovarian stimulation with a gonadotrophin-releasing hormone antagonist protocol. Eur J Obstet Gynecol Reprod Biol. (2019) 236:133–8. doi: 10.1016/j.ejogrb.2019.02.022

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Sadruddin S, Barnett B, Ku L, Havemann D, Mucowski S, Herrington R, et al. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment. PLoS One. (2020) 15:e0239779. doi: 10.1371/journal.pone.0239779

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Bedenk J, Vrtačnik-Bokal E, Virant-Klun I. The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet. (2020) 37:89–100. doi: 10.1007/s10815-019-01622-7

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Yding Andersen C. Inhibin-B secretion and FSH isoform distribution may play an integral part of follicular selection in the natural menstrual cycle. Mol Hum Reprod. (2017) 23:16–24. doi: 10.1093/molehr/gaw070

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Moridi I, Chen A, Tal O, Tal R. The association between Vitamin D and anti-Müllerian hormone: a systematic review and meta-analysis. Nutrients. (2020) 12:1567. doi: 10.3390/nu12061567

CrossRef Full Text | Google Scholar

16. Molinari S, Parissone F, Evasi V, De Lorenzo P, Valsecchi MG, Cesaro S, et al. Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment. Eur J Endocrinol. (2021) 185:717–28. doi: 10.1530/EJE-21-0351

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Zhang F, Liu XL, Rong N, Huang XW. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome. J Huazhong Univ Sci Technolog Med Sci. (2017) 37(1):70–3. doi: 10.1007/s11596-017-1696-x

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Lin XM, Chen M, Wang QL, Ye XM, Chen HF. Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function. World J Clin Cases. (2021) 9:8349–57. doi: 10.12998/wjcc.v9.i28.8349

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Yang L, Zhang H, Zhou L, Gao Y, Yang L, Hu Y, et al. Effect of electro-acupuncture on ovarian function of women with diminished ovarian reserve: study protocol for a randomized controlled trial. Trials. (2021) 22:921. doi: 10.1186/s13063-021-05894-2

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Yetim Sahin A, Bas F, Yetim C. Determination of insulin resistance and its relationship with hyperandrogenemia, anti-müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome. Turk J Med Sci. (2019) 49:1117–25. doi: 10.3906/sag-1808-52

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: ovarian endometriotic cyst, anti-mullerian hormone, inhibin B, follicle stimulating hormone, basic FSH

Citation: Tang Y and Li Y (2022) Evaluation of Serum AMH, INHB Combined with Basic FSH on Ovarian Reserve Function after Laparoscopic Ovarian Endometriosis Cystectomy. Front. Surg. 9:906020. doi: 10.3389/fsurg.2022.906020

Received: 28 March 2022; Accepted: 25 April 2022;
Published: 18 May 2022.

Edited by:

Songwen Tan, Central South University, China

Reviewed by:

Li Genlin, The First Affiliated Hospital, University of South China, China
Lihong Chen, The First Affiliated Hospital of Fujian Medical University, China

Copyright © 2022 Tang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yanning Li NjUwMjMxQGhvc3BpdGFsLmNxbXUuZWR1LmNu

Specialty section: This article was submitted to Visceral Surgery, a section of the journal Frontiers in Surgery

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.